Literature DB >> 16108969

Preventive strategies of renal failure in the Arab world.

Faissal A M Shaheen1, Abdullah A Al-Khader.   

Abstract

The prevalence of both acute and chronic renal failure is high in the Arab world. Data available on the exact prevalence of various renal diseases are very limited. Nevertheless, the reported prevalence of chronic renal failure is 80 to 120 per million population (pmp) in the Kingdom of Saudi Arabia and 225 pmp in Egypt. This is in comparison with the reported prevalence of 283 pmp in Europe, 975 pmp in the United States, and 1149 pmp in Japan. Lower prevalence rates reported in this region could be due to underreporting. The economic burden of renal replacement on health care providers is enormous. In the Kingdom of Saudi Arabia, the estimated cost per annum incurred toward maintenance hemodialysis is US 19,400 US dollars and, considering that there are more than 7200 patients on regular dialysis in this country, the total expenditure is enormous. Such large amounts may be beyond the monetary capacity of many countries in this region because of limited financial resources. These figures clearly suggest that there is an urgent need to establish a massive prevention program. The strategy adapted should be innovative and imaginative and should be one that is maximally cost effective. Paradoxically, in the Arab world, we have a good opportunity to reduce the incidence of kidney failure (chronic and acute) substantially by appropriately chosen models. This is because many of the causes of renal failure are eminently preventable. In fact, a rough estimate is that these programs, if successful, can reduce the incidence by as much as 40% (personal communication, Shaheen, 2003). It is worthy of mention that, in the Arab world, the budget for research is about 0.15% of the national domestic product compared with the international average of 1.5%. In this article, we concentrate on some of the main causes of renal failure in the Arab world that we feel can be prevented and suggest ways that can best address this issue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108969     DOI: 10.1111/j.1523-1755.2005.09807.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  14 in total

Review 1.  Statins in the management of dyslipidemia associated with chronic kidney disease.

Authors:  Murray Epstein; Nosratola D Vaziri
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

2.  Do we have a diabetes epidemic in Libya?

Authors:  Omran Bakoush; Targ Elgzyri
Journal:  Libyan J Med       Date:  2006-10-17       Impact factor: 1.657

3.  How can we achieve global equity in provision of renal replacement therapy?

Authors:  Sarah L White; Steven J Chadban; Stephen Jan; Jeremy R Chapman; Alan Cass
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

4.  Chronic kidney disease in low- and middle-income countries.

Authors:  John W Stanifer; Anthony Muiru; Tazeen H Jafar; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2016-02-04       Impact factor: 5.992

5.  Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review.

Authors:  Amal A Hassanien; Fahdah Al-Shaikh; Eszter P Vamos; Ghasem Yadegarfar; Azeem Majeed
Journal:  JRSM Short Rep       Date:  2012-06-15

6.  Bibliometric analysis of nutrition and dietetics research activity in Arab countries using ISI Web of Science database.

Authors:  Waleed M Sweileh; Samah W Al-Jabi; Ansam F Sawalha; Sa'ed H Zyoud
Journal:  Springerplus       Date:  2014-12-10

7.  Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin.

Authors:  M Al-Maatouq; M Al-Arouj; S H Assaad; S N Assaad; S T Azar; A A K Hassoun; N Jarrah; S Zatari; K G M M Alberti
Journal:  Int J Clin Pract       Date:  2010-01       Impact factor: 2.503

8.  Kidney disease in disadvantaged populations.

Authors:  David Martins; Lawrence Agodoa; Keith Norris
Journal:  Int J Nephrol       Date:  2012-04-09

9.  Knowledge of Chronic Kidney Disease Among the Population of Saudi Arabia Evaluated Using a Validated Questionnaire: A Cross-Sectional Study.

Authors:  Sami Alobaidi
Journal:  Patient Prefer Adherence       Date:  2021-06-14       Impact factor: 2.711

10.  Incidence of end-stage renal disease in the Turkish-Cypriot population of Northern Cyprus: a population based study.

Authors:  Thomas M F Connor; D Deren Oygar; Daniel P Gale; Retha Steenkamp; Dorothea Nitsch; Guy H Neild; Patrick H Maxwell
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.